drugset / Trial / NCT04251871

Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection

NCT04251871

Unknown 150 enrolled Beijing 302 Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to test whether Traditional Chinese Medicines (TCMs) are effective and safe for treating COVID-19 infection. After the enrolment of approximately 30 subjects, the recruitment will be paused, and planned interim analysis will be performed to preliminarily investigate the efficacy and safety of TCMs in patients infected with COVID-19.

Timeline

Start
2020-01-22
Primary completion
2021-01-22
Completion
2021-01-22

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Keguan-1 Traditional medicine (herbal / TCM) 20 g Oral
Comparator Lopinavir Other / unclassified 400 mg
Comparator Ritonavir Other / unclassified 100 mg
Comparator alfa interferon Unknown 50 ug

Indications